{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:55:24Z","timestamp":1770753324212,"version":"3.50.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,8,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>LIN28A and LIN28B, the mammalian homologs of lin-28, are implicated in malignant transformation in part because of their ability to promote degradation of the let-7 family of miRs. In the present study, we show that overexpression of Lin28b in vivo leads to an aggressive peripheral T-cell lymphoma (PTCL) characterized by widespread infiltration of parenchymal organs with malignant CD4+ cells. Similar to patients with PTCL, Lin28b-transgenic mice show signs of inflammation such as eosinophilia, increased C-reactive protein, release of inflammatory cytokines, and pleural effusion. The PTCLs that develop in Lin28b mice are derived from activated T cells and show decreased let-7 expression, increased Il6 expression, activation of NF-\u03baB, and infiltration of B cells, all resulting in an inflammatory microenvironment. In addition, LIN28B is overexpressed 7.5-fold in PTCL patient samples compared with activated CD4+ cells. The results of the present study demonstrate for the first time that Lin28b can transform primary cells in vivo, identify a previously unsuspected link between Lin28b and PTCL, and provide a unique animal model for the study of PTCL biology and therapy.<\/jats:p>","DOI":"10.1182\/blood-2012-01-401760","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T16:25:12Z","timestamp":1340382312000},"page":"1048-1059","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":64,"title":["Enforced expression of Lin28b leads to impaired T-cell development, release of inflammatory cytokines, and peripheral T-cell lymphoma"],"prefix":"10.1182","volume":"120","author":[{"given":"Sarah H.","family":"Beachy","sequence":"first","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Onozawa","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Jo","family":"Chung","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Slape","sequence":"additional","affiliation":[{"name":"Central Clinical School, Monash University, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Bilke","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Princy","family":"Francis","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marbin","family":"Pineda","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Walker","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Meltzer","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Aplan","sequence":"additional","affiliation":[{"name":"Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111808213354900_B1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gene.2006.07.011","article-title":"Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.","volume":"384","author":"Guo","year":"2006","journal-title":"Gene"},{"issue":"5","key":"2019111808213354900_B2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0092-8674(00)81906-6","article-title":"The cold shock domain protein LIN-28 controls developmental timing in C. elegans and is regulated by the lin-4 RNA.","volume":"88","author":"Moss","year":"1997","journal-title":"Cell"},{"issue":"4673","key":"2019111808213354900_B3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.6494891","article-title":"Heterochronic mutants of the nematode Caenorhabditis elegans.","volume":"226","author":"Ambros","year":"1984","journal-title":"Science"},{"issue":"5858","key":"2019111808213354900_B4","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1151526","article-title":"Induced pluripotent stem cell lines derived from human somatic cells.","volume":"318","author":"Yu","year":"2007","journal-title":"Science"},{"issue":"7","key":"2019111808213354900_B5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ng.392","article-title":"Lin28 promotes transformation and is associated with advanced human malignancies.","volume":"41","author":"Viswanathan","year":"2009","journal-title":"Nat Genet"},{"issue":"12","key":"2019111808213354900_B6","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1158\/0008-5472.CAN-10-4637","article-title":"Lin28b promotes colon cancer progression and metastasis.","volume":"71","author":"King","year":"2011","journal-title":"Cancer Res"},{"issue":"4","key":"2019111808213354900_B7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cell.2009.08.002","article-title":"TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation.","volume":"138","author":"Heo","year":"2009","journal-title":"Cell"},{"issue":"9","key":"2019111808213354900_B8","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1073\/pnas.0808300106","article-title":"Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation.","volume":"106","author":"Chang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2019111808213354900_B9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs.","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol"},{"issue":"4","key":"2019111808213354900_B10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"issue":"9","key":"2019111808213354900_B11","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/carcin\/bgq107","article-title":"Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.","volume":"31","author":"Wang","year":"2010","journal-title":"Carcinogenesis"},{"issue":"7","key":"2019111808213354900_B12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ng.593","article-title":"Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies.","volume":"42","author":"Zhu","year":"2010","journal-title":"Nat Genet"},{"issue":"6","key":"2019111808213354900_B13","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.V94.6.1855","article-title":"Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.","volume":"94","author":"Ogilvy","year":"1999","journal-title":"Blood"},{"issue":"17","key":"2019111808213354900_B14","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1158\/0008-5472.CAN-06-3749","article-title":"Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice.","volume":"67","author":"Caudell","year":"2007","journal-title":"Cancer Res"},{"issue":"1","key":"2019111808213354900_B15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/blood.V100.1.246","article-title":"Bethesda proposals for classification of lymphoid neoplasms in mice.","volume":"100","author":"Morse","year":"2002","journal-title":"Blood"},{"key":"2019111808213354900_B16","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"International Agency for Research on Cancer","year":"2008"},{"issue":"3","key":"2019111808213354900_B17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4049\/jimmunol.1101027","article-title":"Cutting edge: regulatory T cells selectively attenuate, not terminate, T cell signaling by disrupting NF-kappa B nuclear accumulation in CD4 T cells.","volume":"188","author":"Huang","year":"2012","journal-title":"J Immunol"},{"issue":"9","key":"2019111808213354900_B18","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/emboj\/16.9.2408","article-title":"An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.","volume":"16","author":"Aplan","year":"1997","journal-title":"EMBO J"},{"issue":"6","key":"2019111808213354900_B19","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2005-07-3013","article-title":"Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia\/lymphoma.","volume":"107","author":"Lin","year":"2006","journal-title":"Blood"},{"issue":"37","key":"2019111808213354900_B20","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.0804507105","article-title":"Transplantation of a myelodysplastic syndrome by a long-term repopulating hematopoietic cell.","volume":"105","author":"Chung","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2019111808213354900_B21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2004-12-4794","article-title":"NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.","volume":"106","author":"Lin","year":"2005","journal-title":"Blood"},{"issue":"10","key":"2019111808213354900_B22","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.4049\/jimmunol.0901121","article-title":"A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement.","volume":"183","author":"Choi","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"2019111808213354900_B23","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.","volume":"183","author":"Pear","year":"1996","journal-title":"J Exp Med"},{"issue":"2","key":"2019111808213354900_B24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 mutations in mouse models of T-ALL.","volume":"107","author":"O'Neil","year":"2006","journal-title":"Blood"},{"issue":"5694","key":"2019111808213354900_B25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"issue":"25","key":"2019111808213354900_B26","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1182\/blood-2010-05-286658","article-title":"Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.","volume":"116","author":"Jeannet","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111808213354900_B27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/carcin\/bgh094","article-title":"Involvement of V(D)J recombinase in the generation of intragenic deletions in the Rit1\/Bcl11b tumor suppressor gene in gamma-ray-induced thymic lymphomas and in normal thymus of the mouse.","volume":"25","author":"Sakata","year":"2004","journal-title":"Carcinogenesis"},{"issue":"8","key":"2019111808213354900_B28","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"issue":"6","key":"2019111808213354900_B29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2008.77","article-title":"Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.","volume":"22","author":"Feldman","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"2019111808213354900_B30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2009.01.002","article-title":"Molecular classification of T-cell lymphomas.","volume":"72","author":"de Leval","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"2019111808213354900_B31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1586\/ehm.11.37","article-title":"Peripheral T-cell lymphoma classification: the matter of cellular derivation.","volume":"4","author":"Piccaluga","year":"2011","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"2019111808213354900_B32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma.","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111808213354900_B33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2141.2003.04335.x","article-title":"Angioimmunoblastic T-cell lymphoma.","volume":"121","author":"Dogan","year":"2003","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111808213354900_B34","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111808213354900_B35","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1084\/jem.187.4.655","article-title":"B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1\/CXCR5.","volume":"187","author":"Legler","year":"1998","journal-title":"J Exp Med"},{"issue":"4","key":"2019111808213354900_B36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.molcel.2010.07.023","article-title":"STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.","volume":"39","author":"Iliopoulos","year":"2010","journal-title":"Mol Cell"},{"issue":"30","key":"2019111808213354900_B37","doi-asserted-by":"crossref","first-page":"27728","DOI":"10.1074\/jbc.M411657200","article-title":"Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes.","volume":"280","author":"Thiefes","year":"2005","journal-title":"J Biol Chem"},{"issue":"17","key":"2019111808213354900_B38","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1182\/blood-2009-09-243535","article-title":"Classical and\/or alternative NF-kappaB pathway activation in multiple myeloma.","volume":"115","author":"Demchenko","year":"2010","journal-title":"Blood"},{"issue":"25","key":"2019111808213354900_B39","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma.","volume":"117","author":"Foss","year":"2011","journal-title":"Blood"},{"issue":"12","key":"2019111808213354900_B40","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/PAS.0b013e31817f123e","article-title":"Peripheral T-cell lymphoma with follicular T-cell markers.","volume":"32","author":"Rodr\u00edguez-Pinilla","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"2019111808213354900_B41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas.","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"2019111808213354900_B42","first-page":"26741","article-title":"T follicular helper (TFH) cells in normal and dysregulated immune responses.","author":"King","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"2019111808213354900_B43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.it.2010.07.001","article-title":"The elusive identity of T follicular helper cells.","volume":"31","author":"Yu","year":"2010","journal-title":"Trends Immunol"},{"issue":"1","key":"2019111808213354900_B44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/eji.200636486","article-title":"The germinal center response is impaired in the absence of T cell-expressed CXCR5.","volume":"37","author":"Arnold","year":"2007","journal-title":"Eur J Immunol"},{"issue":"16","key":"2019111808213354900_B45","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-07-1083","article-title":"The let-7 microRNA represses cell proliferation pathways in human cells.","volume":"67","author":"Johnson","year":"2007","journal-title":"Cancer Res"},{"issue":"6","key":"2019111808213354900_B46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer.","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"issue":"5","key":"2019111808213354900_B47","first-page":"400","article-title":"Chronic inflammation and cancer: the role of the mitochondria.","volume":"25","author":"Kamp","year":"2011","journal-title":"Oncology"},{"issue":"7203","key":"2019111808213354900_B48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation.","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"12","key":"2019111808213354900_B49","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","article-title":"Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.","volume":"19","author":"Mart\u00ednez-Delgado","year":"2005","journal-title":"Leukemia"},{"issue":"14","key":"2019111808213354900_B50","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","article-title":"Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.","volume":"26","author":"Le Gouill","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/5\/1048\/1361785\/zh803112001048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/5\/1048\/1361785\/zh803112001048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:42:26Z","timestamp":1574084546000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/5\/1048\/30266\/Enforced-expression-of-Lin28b-leads-to-impaired"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,2]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,8,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-01-401760","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,2]]}}}